Yan Li; Guangyue Han; Caixiao Jiang; Wenhao Zhou; Minghao Geng; Nana Guo; Wentao Wu; Yamei Wei; Lanfen Liu; Xu Han; Guofan Li; Shangze Liu; Zhihuai Xing; Qi Li; Yan Li; Guangyue Han; Caixiao Jiang; Wenhao Zhou; Minghao Geng; Nana Guo; Wentao Wu; Yamei Wei; Lanfen Liu; Xu Han; Guofan Li; Shangze Liu; Zhihuai Xing; Qi Li

doi:10.46234/ccdcw2025.038

[1]

Calderaro A, Buttrini M, Farina B, Montecchini S, De Conto F, Chezzi C. Respiratory tract infections and laboratory diagnostic methods: a review with A focus on syndromic panel-based assays. Microorganisms 2022;10(9):1856. https://doi.org/10.3390/microorganisms10091856.

[2]

Ding Q, Xu LL, Zhu Y, Xu BP, Chen XP, Duan YL, et al. Comparison of clinical features of acute lower respiratory tract infections in infants with RSV/HRV infection, and incidences of subsequent wheezing or asthma in childhood. BMC Infect Dis 2020;20(1):387. https://doi.org/10.1186/s12879-020-05094-4.

[3]

Zhang L, Wang YP, Xu HM, Hao LP, Zhao B, Ye CC, et al. Prevalence of respiratory viruses in children with acute respiratory infections in Shanghai, China, from 2013 to 2022. Influenza Other Respir Viruses 2024;18(5):e13310. https://doi.org/10.1111/irv.13310.

[4]

Li Y, Yan Y, Huang JM, Shi Y, Du H, Xiong C, et al. Respiratory viruses and Mycoplasma pneumoniae surveillance among hospitalized children with acute respiratory infections - Wuhan City, Hubei Province, China, September-November 2023. China CDC Wkly 2024;6(8):139 − 42. https://doi.org/10.46234/ccdcw2024.027.

[5]

Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 2022;399(10340):2047 − 64. https://doi.org/10.1016/S0140-6736(22)00478-0.

[6]

Eden JS, Sikazwe C, Xie RP, Deng YM, Sullivan SG, Michie A, et al. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions. Nat Commun 2022;13(1):2884. https://doi.org/10.1038/s41467-022-30485-3.

[7]

Hamid S, Winn A, Parikh R, Jones JM, McMorrow M, Prill MM, et al. Seasonality of respiratory syncytial virus—United States, 2017–2023. MMWR Morb Mortal Wkly Rep 2023;72(14):355 − 61. https://doi.org/10.15585/mmwr.mm7214a1.

[8]

Bardsley M, Morbey RA, Hughes HE, Beck CR, Watson CH, Zhao HX, et al. Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study. Lancet Infect Dis 2023;23(1):56 − 66. https://doi.org/10.1016/S1473-3099(22)00525-4.

[9]

Williams TC, Sinha I, Barr IG, Zambon M. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. Euro Surveill 2021;26(29):2100186. https://doi.org/10.2807/1560-7917.ES.2021.26.29.2100186.

[10]

den Hartog G, van Kasteren PB, Schepp RM, Teirlinck AC, van der Klis FRM, van Binnendijk RS. Decline of RSV-specific antibodies during the COVID-19 pandemic. Lancet Infect Dis 2023;23(1):23 − 5. https://doi.org/10.1016/S1473-3099(22)00763-0.

[11]

Hatter L, Eathorne A, Hills T, Bruce P, Beasley R. Respiratory syncytial virus: paying the immunity debt with interest. Lancet Child Adolesc Health 2021;5(12):e44 − 5. https://doi.org/10.1016/S2352-4642(21)00333-3.

[12]

Yang Q, Xiao X, Gu XX, Liang D, Cao T, Mou J, et al. Surveillance of common respiratory infections during the COVID-19 pandemic demonstrates the preventive efficacy of non-pharmaceutical interventions. Int J Infect Dis 2021;105:442 − 7. https://doi.org/10.1016/j.ijid.2021.02.027.